Innoviva (INVA) EPS (Basic) Growth (3y) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 139.68% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 25.99% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 41.58% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 14.28% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 58.35% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -2.92% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 45.92% |
| 10 | Innoviva | 1.60 Bn | 992.84 Mn | 75.83 Mn | 70.32% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 70.32% |
| Dec 31, 2025 | -11.42% |
| Sep 30, 2025 | -30.12% |
| Jun 30, 2025 | 365.70% |
| Mar 31, 2025 | -73.44% |
| Dec 31, 2024 | -31.61% |
| Sep 30, 2024 | -73.21% |
| Jun 30, 2024 | -36.52% |
| Mar 31, 2024 | -14.56% |
| Dec 31, 2023 | -29.86% |
| Sep 30, 2023 | 65.10% |
| Jun 30, 2023 | -70.26% |
| Mar 31, 2023 | -7.77% |
| Dec 31, 2022 | -32.56% |
| Sep 30, 2022 | 113.77% |
| Jun 30, 2022 | -69.99% |
| Mar 31, 2022 | -11.34% |
| Dec 31, 2021 | -26.58% |
| Sep 30, 2021 | 30.31% |
| Jun 30, 2021 | 23.21% |
| Mar 31, 2021 | 47.47% |
| Dec 31, 2020 | -1.23% |
| Sep 30, 2020 | 8.37% |
| Jun 30, 2020 | 32.06% |
| Mar 31, 2020 | 59.56% |
| Dec 31, 2019 | 23.31% |
| Sep 30, 2019 | 40.71% |
| Jun 30, 2019 | 41.72% |
| Mar 31, 2019 | 102.06% |
| Dec 31, 2018 | 302.59% |
| Sep 30, 2018 | 139.57% |
| Jun 30, 2018 | 113.37% |
| Mar 31, 2018 | 73.49% |
| Dec 31, 2017 | 80.99% |
| Sep 30, 2017 | 46.71% |
| Jun 30, 2017 | 56.50% |
| Mar 31, 2017 | 45.29% |
| Dec 31, 2016 | 36.11% |
| Sep 30, 2016 | 52.63% |
| Jun 30, 2016 | 32.98% |
| Mar 31, 2016 | 33.21% |
| Dec 31, 2015 | 28.42% |
| Sep 30, 2015 | 52.36% |
| Jun 30, 2015 | 44.97% |
| Mar 31, 2015 | -27.84% |
| Dec 31, 2014 | 32.24% |
| Sep 30, 2014 | 19.92% |
| Jun 30, 2014 | 16.57% |
| Mar 31, 2014 | 18.78% |
| Dec 31, 2013 | -22.54% |
| Sep 30, 2013 | 32.30% |
| Jun 30, 2013 | -9.74% |